Giuseppina Rea

4PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersEmergency medicineMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.

Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio

|Jan 21, 2023
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury.

Aniello Schiano Moriello, Fiorentina Roviezzo, Fabio Arturo Iannotti

|Oct 24, 2020
NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.

Vincenzo Quagliariello, Michelino De Laurentiis, Stefania Cocco

|Aug 30, 2020
Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study.

Claudia von Arx, Giuseppina Rea, Maria Napolitano

Pageof 1

Frequent Collaborators

1 joint publications

Claudia von Arx

1 joint publications

Alessandro Ottaiano

1 joint publications

Fabiana Tatangelo

1 joint publications

Francesco Izzo